Simon Gibbons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simon Gibbons has a total of 175 co-authors. Here are the top co-authors by number of shared publications:
- Franz Bucar
Institute of Pharmaceutical Sciences, Department of Pharmacognosy, University of Graz, Beethovenstraße 8, 8010 Graz, Austria
8 shared publications - Kaleab Asres
Department of Pharmaceutical chemistry and Pharmacognosy, Addis Ababa University, Addis Ababa, Ethiopia
6 shared publications - M. Mukhlesur Rahman
Centre for Pharmacognosy and Phytotherapy, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK
6 shared publications Paul Stapleton
Research Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK
6 shared publications- Alan Douglas Kinghorn
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
5 shared publications - Amirhossein Sahebkar
Mashhad University of Medical Sciences
5 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Beilstein Institut in Beilstein Archives
- Vol. 2026 (1) , 39
The Geometry of Chemical Reactivity
Chemical reactions often reorganise abruptly with small changes in solvent, catalyst, or excitation, yet such discontinuities are difficult to rationalise using potential energy surfaces alone. Here I show that reactivity is governed by the geometry of constraint‑defined state space. In this Boundary Theory (BT) framework, a chemical system occupies an admissible domain whose boundary (∂Ω) determines which reaction pathways exist. The contrast between tert -butyl chloride (S N 1) and methyl bromide (S N 2) shows how curvature on ∂Ω determines accessible pathways. Deformation of ∂Ω by external or internal constraints creates or eliminates continuous trajectories, providing a unified geometric explanation for S N 1/S N 2 switching, E1/E2/E1cB behaviour, rearrangement cascades, and pericyclic allowedness. Mechanisms correspond to accessible geodesics on ∂Ω rather than discrete stepwise sequences. By thinking of chemical reactivity in terms of boundary accessibility, BT offers a general geometric framework for predicting when reactions appear, vanish, or reorganise.
- 27 October 2026
- Published by Beilstein Institut in Beilstein Archives
- Vol. 2026 (1) , 39
Open AccessThe Geometry of Chemical Reactivity
Chemical reactions often reorganise abruptly with small changes in solvent, catalyst, or excitation, yet such discontinuities are difficult to rationalise using potential energy surfaces alone. Here I show that reactivity is governed by the geometry of constraint‑defined state space. In this Boundary Theory (BT) framework, a chemical system occupies an admissible domain whose boundary (∂Ω) determines which reaction pathways exist. The contrast between tert -butyl chloride (S N 1) and methyl bromide (S N 2) shows how curvature on ∂Ω determines accessible pathways. Deformation of ∂Ω by external or internal constraints creates or eliminates continuous trajectories, providing a unified geometric explanation for S N 1/S N 2 switching, E1/E2/E1cB behaviour, rearrangement cascades, and pericyclic allowedness. Mechanisms correspond to accessible geodesics on ∂Ω rather than discrete stepwise sequences. By thinking of chemical reactivity in terms of boundary accessibility, BT offers a general geometric framework for predicting when reactions appear, vanish, or reorganise.
- Open Access
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (21) , 21715-21730
Semisynthesis of Novel Alicyclic Triterpene-Triazole Derivatives from Boswellia sacra Gum Resin: Potential Anti-breast Cancer and Immunomodulatory Effects on T-Cell Activation
In this current work, we report on the design, synthesis, cytotoxicity of new compounds, molecular docking studies, and in vitro and in silico evaluations of 24 new alicyclic triterpene amide-containing 1H-1,2,3-triazole derivatives (4, 5, 7a-7k and 8a–8k). All new compounds were characterized by 1H-, 13C-, 19F-NMR, and HR-ESI-MS spectroscopic techniques. X-ray crystallography unambiguously confirmed the exact structure of 4. The antibreast cancer activity of all compounds was evaluated against two prominent human breast and one normal cancer cell lines with IC50 values ranging from 352.31 to 61.47 μM (MDA-MB-231), 386.61 to 67.02 μM (MCF-7), and 445.37 to 103.41 μM (HDF), respectively. Eight derivatives (7b–7i) exhibited greater antiproliferative activities than the β-KBA (2) used as a reference compound. Compound 7f demonstrated noteworthy activity even at lower concentrations. In contrast, compounds 8a and 8k demonstrated relatively lower effects, being compared with parent compound 2. Furthermore, compound 7f significantly expanded CD4+ CD8- helper T cell population at both 5 and 10 μM concentrations, increasing the expression of PD-1 and TIGIT immune checkpoints at 5 μM. The binding modes of the most active hits (7b–7i) were deduced by in silico docking using cyclin-dependent kinase 4 (CDK4) as a prominent target. The molecular docking studies demonstrated appreciable binding interactions and docking scores of compounds at CDK-4 ligand binding site and a significant role for −OH in compound 2 and the amide linker and triazole moiety in the binding of these compounds.
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (21) , 21715-21730
Open AccessSemisynthesis of Novel Alicyclic Triterpene-Triazole Derivatives from Boswellia sacra Gum Resin: Potential Anti-breast Cancer and Immunomodulatory Effects on T-Cell Activation
In this current work, we report on the design, synthesis, cytotoxicity of new compounds, molecular docking studies, and in vitro and in silico evaluations of 24 new alicyclic triterpene amide-containing 1H-1,2,3-triazole derivatives (4, 5, 7a-7k and 8a–8k). All new compounds were characterized by 1H-, 13C-, 19F-NMR, and HR-ESI-MS spectroscopic techniques. X-ray crystallography unambiguously confirmed the exact structure of 4. The antibreast cancer activity of all compounds was evaluated against two prominent human breast and one normal cancer cell lines with IC50 values ranging from 352.31 to 61.47 μM (MDA-MB-231), 386.61 to 67.02 μM (MCF-7), and 445.37 to 103.41 μM (HDF), respectively. Eight derivatives (7b–7i) exhibited greater antiproliferative activities than the β-KBA (2) used as a reference compound. Compound 7f demonstrated noteworthy activity even at lower concentrations. In contrast, compounds 8a and 8k demonstrated relatively lower effects, being compared with parent compound 2. Furthermore, compound 7f significantly expanded CD4+ CD8- helper T cell population at both 5 and 10 μM concentrations, increasing the expression of PD-1 and TIGIT immune checkpoints at 5 μM. The binding modes of the most active hits (7b–7i) were deduced by in silico docking using cyclin-dependent kinase 4 (CDK4) as a prominent target. The molecular docking studies demonstrated appreciable binding interactions and docking scores of compounds at CDK-4 ligand binding site and a significant role for −OH in compound 2 and the amide linker and triazole moiety in the binding of these compounds.
- Open Access
- 27 August 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (8) , 001496
Natural products from food sources can alter the spread of antimicrobial resistance plasmids in Enterobacterales
Antimicrobial resistance (AMR) poses a significant threat to global public health. Notably, resistance to carbapenem and extended-spectrum β-lactam antibiotics in Gram-negative bacteria is a major impediment to treating infections. Genes responsible for antibiotic resistance are frequently carried on plasmids, which can transfer between bacteria. Therefore, exploring strategies to prevent this transfer and the prevalence of AMR plasmids is timely and pertinent. Here, we show that certain natural product extracts and associated pure compounds can reduce the conjugation of AMR plasmids into new bacterial hosts. Using our established high-throughput fluorescence-based flow cytometry assay, we found that the natural products were more active in reducing transmission of the IncK extended-spectrum β-lactamase-encoding plasmid pCT in Escherichia coli EC958c, compared to Klebsiella pneumoniae Ecl8 carrying the IncFII carbapenemase-encoding plasmid pKpQIL. The exception was the natural product rottlerin, also active in K. pneumoniae. In classical conjugation assays, rottlerin also reduced the conjugation frequency of the IncFII bla NDM-1 carrying plasmid pCPE16_3 from a clinical K. pneumoniae isolate. Our data indicate that the natural products tested here, in their current molecular structure, reduced conjugation by a small amount, which is unlikely to achieve a large-scale reduction in AMR in bacterial populations. However, certain natural products like rottlerin could provide a foundation for further research into compounds with effective anti-plasmid activity.
- 27 August 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (8) , 001496
Open AccessNatural products from food sources can alter the spread of antimicrobial resistance plasmids in Enterobacterales
Antimicrobial resistance (AMR) poses a significant threat to global public health. Notably, resistance to carbapenem and extended-spectrum β-lactam antibiotics in Gram-negative bacteria is a major impediment to treating infections. Genes responsible for antibiotic resistance are frequently carried on plasmids, which can transfer between bacteria. Therefore, exploring strategies to prevent this transfer and the prevalence of AMR plasmids is timely and pertinent. Here, we show that certain natural product extracts and associated pure compounds can reduce the conjugation of AMR plasmids into new bacterial hosts. Using our established high-throughput fluorescence-based flow cytometry assay, we found that the natural products were more active in reducing transmission of the IncK extended-spectrum β-lactamase-encoding plasmid pCT in Escherichia coli EC958c, compared to Klebsiella pneumoniae Ecl8 carrying the IncFII carbapenemase-encoding plasmid pKpQIL. The exception was the natural product rottlerin, also active in K. pneumoniae. In classical conjugation assays, rottlerin also reduced the conjugation frequency of the IncFII bla NDM-1 carrying plasmid pCPE16_3 from a clinical K. pneumoniae isolate. Our data indicate that the natural products tested here, in their current molecular structure, reduced conjugation by a small amount, which is unlikely to achieve a large-scale reduction in AMR in bacterial populations. However, certain natural products like rottlerin could provide a foundation for further research into compounds with effective anti-plasmid activity.
- Top Cited PapersOpen Access
- 13 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8792
Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation
Phytochemicals have a long and successful history in drug discovery. With recent advancements in analytical techniques and methodologies, discovering bioactive leads from natural compounds has become easier. Computational techniques like molecular docking, QSAR modelling and machine learning, and network pharmacology are among the most promising new tools that allow researchers to make predictions concerning natural products’ potential targets, thereby guiding experimental validation efforts. Additionally, approaches like LC-MS or LC-NMR speed up compound identification by streamlining analytical processes. Integrating structural and computational biology aids in lead identification, thus providing invaluable information to understand how phytochemicals interact with potential targets in the body. An emerging computational approach is machine learning involving QSAR modelling and deep neural networks that interrelate phytochemical properties with diverse physiological activities such as antimicrobial or anticancer effects.
- 13 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8792
Top Cited PapersOpen AccessPhytochemicals in Drug Discovery—A Confluence of Tradition and Innovation
Phytochemicals have a long and successful history in drug discovery. With recent advancements in analytical techniques and methodologies, discovering bioactive leads from natural compounds has become easier. Computational techniques like molecular docking, QSAR modelling and machine learning, and network pharmacology are among the most promising new tools that allow researchers to make predictions concerning natural products’ potential targets, thereby guiding experimental validation efforts. Additionally, approaches like LC-MS or LC-NMR speed up compound identification by streamlining analytical processes. Integrating structural and computational biology aids in lead identification, thus providing invaluable information to understand how phytochemicals interact with potential targets in the body. An emerging computational approach is machine learning involving QSAR modelling and deep neural networks that interrelate phytochemical properties with diverse physiological activities such as antimicrobial or anticancer effects.
- Open Access
Caudiquinol: A Meroterpenoid with an Intact C20 Geranylgeranyl Chain Isolated from Garcinia caudiculata
The tropical Garcinia genus of flowering plants is a prolific producer of aromatic natural products including polyphenols, flavonoids, and xanthones. In this study, we report the first phytochemical investigation of Garcinia caudiculata Ridl. from the island of Borneo. Fractionation, purification, and structure elucidation by MS and NMR resulted in the discovery of two meroterpenoids. One was a benzofuranone lactone previously isolated from Iryanthera grandis and Rhus chinensis, and the second was a new hydroquinone methyl ester that we named caudiquinol. Both natural products are rare examples of plant meroterpenoids with an intact geranylgeranyl chain.
Open AccessCaudiquinol: A Meroterpenoid with an Intact C20 Geranylgeranyl Chain Isolated from Garcinia caudiculata
The tropical Garcinia genus of flowering plants is a prolific producer of aromatic natural products including polyphenols, flavonoids, and xanthones. In this study, we report the first phytochemical investigation of Garcinia caudiculata Ridl. from the island of Borneo. Fractionation, purification, and structure elucidation by MS and NMR resulted in the discovery of two meroterpenoids. One was a benzofuranone lactone previously isolated from Iryanthera grandis and Rhus chinensis, and the second was a new hydroquinone methyl ester that we named caudiquinol. Both natural products are rare examples of plant meroterpenoids with an intact geranylgeranyl chain.
- 23 July 2024
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 87 (8) , 2132-2138
The 6Ps of Preparing a Manuscript: Prior Preparation Prevents Potentially Poor Performance
The process of writing a scientific document, whether it be a PhD thesis, a paper, review, chapter, book or even a book series, always begins with only one word. Why can writing a manuscript be so difficult to start? If there are sufficient data for the task, there is only one reason; vacillation. To address this serious and psychologically debilitating issue, this perspective will discuss the ethos of publishing and provide a solution for vacillation. The concept of sufficient novel data will be examined along with the criteria for identifying an appropriate home for a manuscript. The bare process of preparation will be described, which ultimately relies on discipline, routine, formatting and further discipline, with the ultimate goal being the production and quality control of a manuscript of the highest quality that you can achieve. The value of the secondary literature, namely reviews, chapters and books will be highlighted, specifically with regard to the building of a reputation and leaving a lasting legacy. The psychology of publishing, particularly dealing with success and failure will be covered, as this topic is often overlooked, and can have serious and deleterious mental health consequences. A balanced view of publication metrics will be given, showing that such factors are in some cases, purely a business strategy for publishing houses. Ideas to build one's career through networking, reviewing and being an ambassador for one's discipline are also given. As a former member of the Editorial Advisory Board of the Journal of Natural Products (2018-2022), an overview of the manuscript writing process from a personal and professional perspective is emphasized to encourage all to avoid the trials and tribulations of procrastination.
- 23 July 2024
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 87 (8) , 2132-2138
The 6Ps of Preparing a Manuscript: Prior Preparation Prevents Potentially Poor Performance
The process of writing a scientific document, whether it be a PhD thesis, a paper, review, chapter, book or even a book series, always begins with only one word. Why can writing a manuscript be so difficult to start? If there are sufficient data for the task, there is only one reason; vacillation. To address this serious and psychologically debilitating issue, this perspective will discuss the ethos of publishing and provide a solution for vacillation. The concept of sufficient novel data will be examined along with the criteria for identifying an appropriate home for a manuscript. The bare process of preparation will be described, which ultimately relies on discipline, routine, formatting and further discipline, with the ultimate goal being the production and quality control of a manuscript of the highest quality that you can achieve. The value of the secondary literature, namely reviews, chapters and books will be highlighted, specifically with regard to the building of a reputation and leaving a lasting legacy. The psychology of publishing, particularly dealing with success and failure will be covered, as this topic is often overlooked, and can have serious and deleterious mental health consequences. A balanced view of publication metrics will be given, showing that such factors are in some cases, purely a business strategy for publishing houses. Ideas to build one's career through networking, reviewing and being an ambassador for one's discipline are also given. As a former member of the Editorial Advisory Board of the Journal of Natural Products (2018-2022), an overview of the manuscript writing process from a personal and professional perspective is emphasized to encourage all to avoid the trials and tribulations of procrastination.
- Open Access
- 17 June 2024
- Published by MDPI AG in Preprints.org
Phytochemicals in Drug Discovery - A Confluence of Tradition and Innovation
Phytochemicals have a long and successful history in drug discovery. With recent advancements in analytical techniques and methodologies, discovering bioactive leads from natural compounds has become easier. Computational techniques like molecular docking, QSAR modelling and machine learning, and network pharmacology are among the most promising new tools that allow researchers to make predictions concerning natural products' potential targets, thereby guiding experimental validation efforts. Additionally, approaches like LC-MS or LC-NMR speed up compound identification by streamlining analytical processes. Integrating structural and computational biology aids in lead identification, thus providing invaluable information to understand how phytochemicals interact with potential targets in the body. Emerging computational approach is machine learning involving QSAR modelling and deep neural networks that interrelate phytochemical properties with diverse physiological activities such as antimicrobial or anticancer effects.
- 17 June 2024
- Published by MDPI AG in Preprints.org
Open AccessPhytochemicals in Drug Discovery - A Confluence of Tradition and Innovation
Phytochemicals have a long and successful history in drug discovery. With recent advancements in analytical techniques and methodologies, discovering bioactive leads from natural compounds has become easier. Computational techniques like molecular docking, QSAR modelling and machine learning, and network pharmacology are among the most promising new tools that allow researchers to make predictions concerning natural products' potential targets, thereby guiding experimental validation efforts. Additionally, approaches like LC-MS or LC-NMR speed up compound identification by streamlining analytical processes. Integrating structural and computational biology aids in lead identification, thus providing invaluable information to understand how phytochemicals interact with potential targets in the body. Emerging computational approach is machine learning involving QSAR modelling and deep neural networks that interrelate phytochemical properties with diverse physiological activities such as antimicrobial or anticancer effects.
- Open Access
- 22 September 2020
- Published by Wiley in Phytotherapy Research
- Vol. 34 (9) , 2083-2084
Issue Information
- 22 September 2020
- Published by Wiley in Phytotherapy Research
- Vol. 34 (9) , 2083-2084
Open AccessIssue Information
- Open Access
- 28 April 2020
- Published by Wiley in Phytotherapy Research
- Vol. 34 (5) , 905-906
Issue Information
- 28 April 2020
- Published by Wiley in Phytotherapy Research
- Vol. 34 (5) , 905-906
Open AccessIssue Information
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 1604638
Myristica lowiana Phytochemicals as Inhibitor of Plasmid Conjugation in Escherichia coli
Hexane extract and methanol fraction from the stem bark of Myristica lowiana specifically and significantly inhibited the conjugal transfer of the IncW plasmid R7K, a plasmid which harbors ampicillin‐, streptomycin‐, and spectinomycin‐resistant genes. The transfer of this plasmid via the conjugative pilli of Escherichia coli was reduced by 76.5 ± 2.0% and 79.0 ± 1.2% by hexane extract and methanol fraction of M. lowiana, respectively. The hexane extract exhibited significant anti‐conjugant activity at a non‐cytotoxic concentration of 100 mg/L as assessed against adult human dermal fibroblast cells. The hexane extract and methanol fraction were screened using phytochemical tests, NMR spectroscopy, IR spectroscopy, and high‐resolution electrospray ionization mass spectrometry (HRESIMS) and were found to contain terpenoids, sterols, and fatty acids.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 1604638
Open AccessMyristica lowiana Phytochemicals as Inhibitor of Plasmid Conjugation in Escherichia coli
Hexane extract and methanol fraction from the stem bark of Myristica lowiana specifically and significantly inhibited the conjugal transfer of the IncW plasmid R7K, a plasmid which harbors ampicillin‐, streptomycin‐, and spectinomycin‐resistant genes. The transfer of this plasmid via the conjugative pilli of Escherichia coli was reduced by 76.5 ± 2.0% and 79.0 ± 1.2% by hexane extract and methanol fraction of M. lowiana, respectively. The hexane extract exhibited significant anti‐conjugant activity at a non‐cytotoxic concentration of 100 mg/L as assessed against adult human dermal fibroblast cells. The hexane extract and methanol fraction were screened using phytochemical tests, NMR spectroscopy, IR spectroscopy, and high‐resolution electrospray ionization mass spectrometry (HRESIMS) and were found to contain terpenoids, sterols, and fatty acids.